Document is current

Any future updates will be listed below

Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib – novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled

Crossref DOI link: https://doi.org/10.1186/s12964-026-02893-1

Published Online: 2026-05-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark